Fresenius Medical Care AG
DUS:FME
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
F
|
Fresenius Medical Care AG
DUS:FME
|
DE |
|
M
|
Moody's Corp
XMUN:DUT
|
US |
|
M
|
Metro AG
SWB:B4B3
|
DE |
|
Holcim AG
F:HLBN
|
CH |
|
Pool Corp
NASDAQ:POOL
|
US |
|
Baidu Inc
F:B1CB
|
CN |
|
A
|
Anhui Conch Cement Co Ltd
XMUN:AQE
|
CN |
Wall St Price Targets
FME Price Targets Summary
Fresenius Medical Care AG
According to Wall Street analysts, the average 1-year price target for FME is 40.99 EUR with a low forecast of 22.4 EUR and a high forecast of 61.94 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is FME's stock price target?
Price Target
40.99
EUR
According to Wall Street analysts, the average 1-year price target for FME is 40.99 EUR with a low forecast of 22.4 EUR and a high forecast of 61.94 EUR.
What is the Revenue forecast for Fresenius Medical Care AG?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 8 years is 4%.
What is the Gross Profit forecast for Fresenius Medical Care AG?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 2%. The projected CAGR for the next 8 years is 5%.
What is the Operating Income forecast for Fresenius Medical Care AG?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Operating Income has been 0%. The projected CAGR for the next 8 years is 8%.
What is the Pre-Tax Income forecast for Fresenius Medical Care AG?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 0%. The projected CAGR for the next 3 years is 12%.
What is the Net Income forecast for Fresenius Medical Care AG?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Net Income has been 0%. The projected CAGR for the next 8 years is 8%.
